127 related articles for article (PubMed ID: 26548936)
1. A meta-analysis of lentinan injection combined with chemotherapy in the treatment of nonsmall cell lung cancer.
Yin X; Ying J; Li L; Zhang H; Wang H
Indian J Cancer; 2015 Nov; 52 Suppl 1():e29-31. PubMed ID: 26548936
[TBL] [Abstract][Full Text] [Related]
2. Lentinan combined with cisplatin for the treatment of non-small cell lung cancer.
Zhao C; Yan H; Pang W; Wu T; Kong X; Li X; Liu H; Zhao L; Liang F; Jia Y
Medicine (Baltimore); 2021 Mar; 100(12):e25220. PubMed ID: 33761711
[TBL] [Abstract][Full Text] [Related]
3. Aidi injection plus platinum-based chemotherapy for stage IIIB/IV non-small cell lung cancer: A meta-analysis of 42 RCTs following the PRISMA guidelines.
Wang J; Li G; Yu L; Mo T; Wu Q; Zhou Z
J Ethnopharmacol; 2018 Jul; 221():137-150. PubMed ID: 29655852
[TBL] [Abstract][Full Text] [Related]
4. Elemene injection as adjunctive treatment to platinum-based chemotherapy in patients with stage III/IV non-small cell lung cancer: A meta-analysis following the PRISMA guidelines.
Wang X; Liu Z; Sui X; Wu Q; Wang J; Xu C
Phytomedicine; 2019 Jun; 59():152787. PubMed ID: 31005810
[TBL] [Abstract][Full Text] [Related]
5. Assessment on the Efficacy and Safety of Aidi Injection Combined with Vinorelbine and Cisplatin for Treatment of Advanced Nonsmall Cell Lung Cancer.
Zhao HY; Zhou HY; Wang YT; Chen W; Qi SY; Cao JL; Li GH
Chin Med J (Engl); 2016 Mar; 129(6):723-30. PubMed ID: 26960377
[TBL] [Abstract][Full Text] [Related]
6. Injectable Chinese herbal formula Kang'ai for nonsmall cell lung cancer: Trial sequential analysis of 2,259 participants from 31 randomized controlled trials.
He XR; Han SY; Li PP
J Cancer Res Ther; 2016; 12(2):735-43. PubMed ID: 27461643
[TBL] [Abstract][Full Text] [Related]
7. Kanglaite injection combined with chemotherapy versus chemotherapy alone in the treatment of advanced non-small cell lung carcinoma.
Liu X; Yang Q; Xi Y; Yu K; Wang W; Zhao X; Kou X
J Cancer Res Ther; 2014 Aug; 10 Suppl 1():46-51. PubMed ID: 25207891
[TBL] [Abstract][Full Text] [Related]
8. Meta-analysis comparing doublet and single cytotoxic agent therapy as first-line treatment in elderly patients with advanced nonsmall-cell lung cancer.
Wang S; Wang Q; Tian J; Zhou Z; Jiao L; Fu Y; Chen S; Zhang J; Xu L
J Int Med Res; 2015 Dec; 43(6):727-37. PubMed ID: 26438014
[TBL] [Abstract][Full Text] [Related]
9. Traditional Chinese medicinal herbs combined with epidermal growth factor receptor tyrosine kinase inhibitor for advanced non-small cell lung cancer: a systematic review and meta-analysis.
Liu ZL; Zhu WR; Zhou WC; Ying HF; Zheng L; Guo YB; Chen JX; Shen XH
J Integr Med; 2014 Jul; 12(4):346-58. PubMed ID: 25074884
[TBL] [Abstract][Full Text] [Related]
10. Unresected stage III non-small-cell lung cancer. Provincial Lung Cancer Disease Site Group.
Okawara G; Rusthoven J; Newman T; Findlay B; Evans W
Cancer Prev Control; 1997 Aug; 1(3):249-59. PubMed ID: 9765750
[TBL] [Abstract][Full Text] [Related]
11. Endostar combined with chemotherapy compared with chemotherapy alone in the treatment of nonsmall lung carcinoma: A meta-analysis based on Chinese patients.
Wang J; Gu LJ; Fu CX; Cao Z; Chen QY
Indian J Cancer; 2014 Mar; 51 Suppl 3():e106-9. PubMed ID: 25818734
[TBL] [Abstract][Full Text] [Related]
12. [Meta-analysis of Cinobufacini Injection combined with platinum-contained first-line chemotherapy in treatment of non-small cell lung cancer].
Xu Y; Han D; Feng FC; Wang ZC; Gu C; Peng WP; He HL; Zhou XM
Zhongguo Zhong Yao Za Zhi; 2019 Nov; 44(21):4728-4737. PubMed ID: 31872671
[TBL] [Abstract][Full Text] [Related]
13. [Intercalated Combination of Chemotherapy and EGFR-TKIs versus Chemotherapy Alone in the First-line Treatment of Advanced Non-small Cell Lung Cancer: A Meta-analysis].
Hong C; Mei T; Wang J
Zhongguo Fei Ai Za Zhi; 2016 Dec; 19(12):837-846. PubMed ID: 27978869
[TBL] [Abstract][Full Text] [Related]
14. The effect of kanglaite injection in combination with gefitinib versus gefitinib alone in patients with nonsmall cell lung cancer: A meta-analysis.
Hailang H; Jiping Z; Ailing C; Xianmei Z
J Cancer Res Ther; 2020; 16(4):745-751. PubMed ID: 32930113
[TBL] [Abstract][Full Text] [Related]
15. [Systematic review and Meta-analysis of Shenqi Fuzheng injection combined with first-line chemotherapy for non-small cell lung cancer].
Hao TT; Xie YM; Liao X; Wang J
Zhongguo Zhong Yao Za Zhi; 2015 Oct; 40(20):4094-107. PubMed ID: 27062833
[TBL] [Abstract][Full Text] [Related]
16. Effects of Shengmai injection add-on therapy to chemotherapy in patients with non-small cell lung cancer: a meta-analysis.
Duan B; Xie J; Rui Q; Zhang W; Xi Z
Support Care Cancer; 2018 Jul; 26(7):2103-2111. PubMed ID: 29594484
[TBL] [Abstract][Full Text] [Related]
17. Clinical efficacy and safety of NSCLC ancillary treatment with compound Kushen injection through immunocompetence regulation: A systematic review and meta-analysis.
Wang D; Xu Y; Huang T; Peng W; Zhu D; Zhou X; Wu Q
Phytomedicine; 2022 Sep; 104():154315. PubMed ID: 35868145
[TBL] [Abstract][Full Text] [Related]
18. Safety and tolerability of PD-1/PD-L1 inhibitors in the treatment of non-small cell lung cancer: a meta-analysis of randomized controlled trials.
Luo W; Wang Z; Tian P; Li W
J Cancer Res Clin Oncol; 2018 Oct; 144(10):1851-1859. PubMed ID: 30019319
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of chemotherapy or tyrosine kinase inhibitors combined with bevacizumab versus chemotherapy or tyrosine kinase inhibitors alone in the treatment of non-small cell lung cancer: a systematic review and meta-analysis.
Sun L; Ma JT; Zhang SL; Zou HW; Han CB
Med Oncol; 2015 Feb; 32(2):473. PubMed ID: 25603953
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of biological response modifier lentinan with chemotherapy for advanced cancer: a meta-analysis.
Wang H; Cai Y; Zheng Y; Bai Q; Xie D; Yu J
Cancer Med; 2017 Oct; 6(10):2222-2233. PubMed ID: 28940986
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
